RNA

Research spotlight: Study finds a protective kidney RNA that could transform disease treatment - EurekAlert!

RNA viruses may differentially shape carbon recycling in the ocean - EurekAlert!

Viome and Scripps Research Partner to develop first at-home RNA screening test to prevent colon cancer before it strikes - EurekAlert!

Innovative liquid biopsy test uses RNA to detect early-stage cancer - EurekAlert!

Study uncovers how harmful RNA clumps form — and a way to dissolve them - EurekAlert!

New way to improve the efficacy of innovative RNA therapies - EurekAlert!

RNA codon expansion via programmable pseudouridine editing and decoding - EurekAlert!

New noncoding RNA identified as key regulator in ovarian cell survival - EurekAlert!

Unraveling tumor heterogeneity: Quantitative insights from single-cell RNA sequencing analysis in breast cancer subtypes - EurekAlert!

Chemists recreate how RNA might have reproduced for first time

Chemists recreate how RNA might have reproduced for first time - EurekAlert!

Early prediction of preterm birth in cell-free RNA may revolutionize prevention strategies - EurekAlert!

Modulation of antiviral response in fungi via RNA editing

Modulation of antiviral response in fungi via RNA editing - EurekAlert!

Novel biosensor illuminates plant RNA in real time - EurekAlert!

RNA-binding proteins and circular RNAs: A new frontier in cancer therapy - EurekAlert!

How a tiny RNA modification helps control cell stress responses - EurekAlert!

Editing Parkinson's Disease – KAIST makes world's first discovery of an inflammatory RNA editing enzyme - EurekAlert!

A new druggable cancer target: RNA-binding proteins on the cell surface - EurekAlert!

Restoring healthy gene expression with programmable therapeutics. CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.